Cardiac involvement in pediatric hemolytic uremic syndrome. - Université de Lille Accéder directement au contenu
Article Dans Une Revue Pediatric Nephrology Année : 2022

Cardiac involvement in pediatric hemolytic uremic syndrome.

Résumé

Background Cardiac involvement is a known but rare complication of pediatric hemolytic uremic syndrome (HUS). We conducted a nationwide observational, retrospective case–control study describing factors associated with the occurrence of myocarditis among HUS patients. Methods Cases were defined as hospitalized children affected by any form of HUS with co-existent myocarditis in 8 French Pediatric Intensive Care Units (PICU) between January 2007 and December 2018. Control subjects were children, consecutively admitted with any form of HUS without coexistent myocarditis, at a single PICU in Lyon, France, during the same time period. Results A total of 20 cases of myocarditis were reported among 8 PICUs, with a mean age of 34.3 ± 31.9 months; 66 controls were identified. There were no differences between the two groups concerning the season and the typical, Shiga toxin-producing Escherichia coli (STEC-HUS), or atypical HUS (aHUS). Maximal leukocyte count was higher in the myocarditis group (29.1 ± 16.3G/L versus 21.0 ± 9.9G/L, p = 0.04). The median time between admission and first cardiac symptoms was of 3 days (range 0–19 days), and 4 patients displayed myocarditis at admission. The fatality rate in the myocarditis group was higher than in the control group (40.0% versus 1.5%, p < 0.001). Thirteen (65%) children from the myocarditis group received platelet transfusion compared to 19 (29%) in the control group (p = 0.03). Conclusion Our study confirms that myocarditis is potentially lethal and identifies higher leukocyte count and platelet transfusion as possible risk factors of myocarditis.
Fichier non déposé

Dates et versions

hal-04390786 , version 1 (12-01-2024)

Identifiants

Citer

Corentin Tanné, Etienne Javouhey, Olivia Boyer, Morgan Recher, Emma Allain-Launay, et al.. Cardiac involvement in pediatric hemolytic uremic syndrome.. Pediatric Nephrology, 2022, Pediatric Nephrology, ⟨10.1007/s00467-022-05427-2⟩. ⟨hal-04390786⟩
33 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More